Member Info for Mikeworrall

Great to see the price going up and everything in the blue! Hopefully, we’ll be back on track soon.

Celadon Pharmaceuticals has made significant strides, which should give investors confidence despite short-term fluctuations in the share price. With the expansion of their facilities to meet increasing demand, Celadon is well-positioned for growth.

I hear you, the share price might be down a bit today, but it'll definitely be promising to see a big buy order.

With the UK cannabis market projected to hit £1bn by 2026, and Celadon's solid positioning, I'm confident we'll see a rebound. Keep the faith and hold steady

With any luck, this will spark some renewed interest and we’ll start to see some positive momentum.

Market fluctuations are par for the course. Remember, Celadon is a strong contender in a rapidly growing industry.

With the recent uptick in liquidity in the junior markets, I reckon we're on the brink of seeing some exciting movement

Absolutely, With the current momentum, Celadon is well-positioned to benefit. I believe we could see some significant movement here very soon. Let's keep an eye on the developments!

The UK cannabis market could be worth as much as £1bn by 2026, according to market intelligence firm Prohibition Partners. Meanwhile, the US market is already valued at $9 billion, according to Global Market Insights. Celadon is a major player in this industry and stands to benefit significantly from this growth. Keep buying and hold on tight

Considering the 250k options and the recent sell activity since last Thursday, it seems plausible that these sales could be wrapping up. If that's the case, we might be looking at a prime buying opportunity.

Keep buying the lows! This is a great opportunity to average down the price. Mark my words, it's gonna go up soon.

The recent activity suggests there's quite a bit of interest brewing. If this keeps up, we might see a significant uptick.

Absolutely, mate! Yesterday's trading was something else, wasn't it? The big volume gives me hope that this could be the start of new investors piling in.

Yeah I hope so too

Kingdom's breakthrough drug, KT-20610, targets over 500k children with ASD in the USA by addressing the critical link between gastrointestinal permeability and ASD. With a projected market size exceeding $5bn by 2027 and limited drug options available, KT-20610 is set to revolutionize treatment. Backed by compelling pre-clinical data, the drug significantly improves both behavioral and gastrointestinal functions. Celadon, holding a 20% stake in Kingdom, stands to benefit immensely, especially with their secured supply agreement for the natural API in KT-20610. If successful, the demand for Celadon’s API will skyrocket, making now the perfect time to invest!

Some nice buys going in already this morning, looks like we are set for a high volume day.

Totally agree

WE CAN SEE SOME GOOD VOLUME TODAY